A dedicated customer support program that provides individualized prescription support based on the patient’s maternity benefits.
Submit the prescription online via eMakena iAssist.com
Complete the Makena Prescription Form and fax to the Makena Care Connection®
Get to know the Makena Care Connection® team
The manager of the Makena Care Connection introduces her team and explains how they can help you navigate the prescription process for patients including prior authorizations and financial assistance when needed.
Learn more about Makena Care Connection services
Monday–Friday, 7 AM – 7 PM (CT)
Committed to helping
ensure cost is not a barrier to
acceptance of therapy
Financial assistance is available with no upper-level income caps for eligible insured and uninsured patients in need. Learn more.
Committed to helping patients
adhere to their weekly
A free nurse-led program designed to provide education, support, and empowerment throughout the patient’s pregnancy journey. Learn more.
Committed to helping address
logistical barriers to therapy
Makena @Home provides access to weekly administration of therapy in the home setting via a trusted home healthcare provider when covered by the patient’s insurance. Learn more.
Prime Therapeutics Specialty Pharmacy LLC (Prime Specialty Pharmacy) is a wholly owned subsidiary of Prime Therapeutics LLC.
Makena Care Connection® helped Kate through her prescription process
Kate, a busy mother of a toddler, turned to Makena Care Connection when she was pregnant again to help her get started on Makena® (hydroxyprogesterone caproate injection).
You should receive a confirmation of receipt via fax within a few minutes. If you do not receive this communication, please contact the Makena Care Connection to find out if your patient’s prescription has been received.
The results of the investigation will be relayed to both you and your patient over the phone.
Once the specialty pharmacy receives approval from the patient’s insurance company, the pharmacy will call the patient to arrange for payment and delivery.
See how the Makena Care Connection® team supports you and your office throughout the prescription submission process
The manager of the Makena Care Connection, introduces you to her team and explains how they are dedicated to helping you submit and process patient prescriptions for Makena® (hydroxyprogesterone caproate injection) to ensure on time initiation of therapy.
Let your patients know that timely communication is important
Want to purchase Makena for your office? Learn how
Financial assistance for Makena is available with no upper-level income caps for eligible commercially insured and uninsured patients in need
Eligibility criteria for the assistance programs include:
In compliance with federal regulations, patients insured by a government-funded program (e.g., Medicaid, TRICARE, etc.) are not eligible.
If your patient feels her out-of-pocket cost is too high, she should call the Makena Care Connection to see if she is eligible for financial assistance*
Makena Copay Assistance Program for eligible commercially insured patients
Eligible women can reduce their out-of-pocket cost for Makena® (hydroxyprogesterone caproate injection). Learn more about the commitment of AMAG Pharmaceuticals to affordable access to therapy.
Makena Patient Assistance Program for eligible uninsured patients
Eligible uninsured women can reduce their out-of-pocket cost for Makena® (hydroxyprogesterone caproate injection). Learn more about the commitment of AMAG Pharmaceuticals to affordable access to therapy.
Makena Prescription Form
To initiate the Makena prescription process via the Makena Care Connection.Download
Makena Authorization for Release of Personal Health Information Form (HIPAA form)
If the patient does not sign Step 2 (Patient Authorization) of the Makena Prescription Form, this form may be completed and faxed to the Makena Care Connection at a later date. The HIPAA release form allows the Makena Care Connection to communicate with the healthcare provider, insurer, and specialty pharmacy on the patient's behalf. Note: this form does not need to be completed if the patient has already signed Step 2 of the Makena Prescription Form.English Spanish
Makena (hydroxyprogesterone caproate injection) is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth. The effectiveness of Makena is based on improvement in the proportion of women who delivered <37 weeks of gestation. There are no controlled trials demonstrating a direct clinical benefit, such as improvement in neonatal mortality and morbidity.
Limitation of use: While there are many risk factors for preterm birth, safety and efficacy of Makena has been demonstrated only in women with a prior spontaneous singleton preterm birth. It is not intended for use in women with multiple gestations or other risk factors for preterm birth.
Please see full prescribing information for Makena.
Reference: 1. Makena® (hydroxyprogesterone caproate injection) prescribing information, AMAG Pharmaceuticals, 2016.